Microarray Studies to Discover Novel Host Defenses in SIV Infection
微阵列研究发现 SIV 感染的新型宿主防御
基本信息
- 批准号:8069561
- 负责人:
- 金额:$ 18.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-05-15 至 2012-10-30
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAcuteAfricaAnimal ModelAnimalsAttentionAttenuatedB-LymphocytesCD4 Positive T LymphocytesCervicalCessation of lifeDevelopmentEconomicsEpithelialEquilibriumFutureGene ExpressionHIV-1Host DefenseHumanImmune responseInfectionInflammatoryLifeLightLymphoid TissueMacaca mulattaModelingNatural ImmunityPathogenesisPreventionRecruitment ActivityRiskSIVSystemic infectionT-LymphocyteTimeTissuesUp-RegulationVaccinatedVaccinationVaccinesVaginaVirusWomanWorkadaptive immunitybasedesigninsightmicrobicidenewsnonhuman primatenovelpreventprophylacticpublic health relevanceresponsetransmission processvaginal transmission
项目摘要
DESCRIPTION (provided by applicant): An effective vaccine is needed for prevention of HIV-1 transmission. This proposal is directed to identifying, in the SIV-rhesus macaque animal model, correlates of protection against vaginal transmission conferred by prior infection with an attenuated ?-nef strain of SIV. Microarray transcriptional profiling of cervical, vaginal and lymphatic tissues, at times when the extent of protection differs markedly, is proposed as a means to identify correlates of protection in: (i) particular or novel components of innate and adaptive immunity; (ii) a balanced up-regulation of innate and adaptive immune responses without the pro-inflammatory component that recruits CD4 T cells to fuel local expansion and systemic infection; and (iii) mechanisms of protection related to unexpected components of the innate and adaptive response, mechanisms related to the mucosal epithelial response to virus exposure, or wholly novel defenses suggested by the microarrays. These insights can then be harnessed in future work to design an effective vaccine to protect women from HIV-1 acquisition.
PUBLIC HEALTH RELEVANCE: An effective vaccine to prevent HIV-1 is urgently needed. In this proposal, transcriptional profiles of cervical, vaginal and lymphatic tissues will be determined in infection with an attenuated ?-nef strain of SIV to identify novel correlates of protection with this vaccine approach.
描述(由申请人提供):需要一种有效的疫苗来预防HIV-1传播。该建议旨在确定,在SIV-恒河猴动物模型中,与先前感染减毒?SIV nef株。当保护程度显著不同时,宫颈、阴道和淋巴组织的微阵列转录谱被提出作为鉴定以下保护相关物的手段:(i)先天性和适应性免疫的特定或新组分;(ii)先天性和适应性免疫应答的平衡上调,而没有促-炎性成分,募集CD 4 T细胞以促进局部扩张和全身感染;和(iii)与先天和适应性反应的意外成分相关的保护机制,与粘膜上皮细胞对病毒暴露的反应相关的机制,或由微阵列提出的全新防御机制。这些见解可以在未来的工作中加以利用,以设计一种有效的疫苗来保护妇女免受HIV-1感染。
公共卫生相关性:迫切需要一种有效的疫苗来预防HIV-1。在这项建议中,宫颈,阴道和淋巴组织的转录谱将在感染减毒?nef株的SIV,以确定与这种疫苗方法的保护的新的相关性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ASHLEY T. HAASE其他文献
ASHLEY T. HAASE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ASHLEY T. HAASE', 18)}}的其他基金
A New Approach to Reactivating HIV from Latency
重新激活潜伏期艾滋病毒的新方法
- 批准号:
10212924 - 财政年份:2017
- 资助金额:
$ 18.69万 - 项目类别:
A New Approach to Reactivating HIV from Latency
重新激活潜伏期艾滋病毒的新方法
- 批准号:
9977118 - 财政年份:2017
- 资助金额:
$ 18.69万 - 项目类别:
Vaccine Design to Concentrate Protective Antibodies at the Mucosal Border
将保护性抗体集中在粘膜边界的疫苗设计
- 批准号:
8516458 - 财政年份:2012
- 资助金额:
$ 18.69万 - 项目类别:
Vaccine Design to Concentrate Protective Antibodies at the Mucosal Border
将保护性抗体集中在粘膜边界的疫苗设计
- 批准号:
8683100 - 财政年份:2012
- 资助金额:
$ 18.69万 - 项目类别:
Vaccine Design to Concentrate Protective Antibodies at the Mucosal Border
将保护性抗体集中在粘膜边界的疫苗设计
- 批准号:
8403858 - 财政年份:2012
- 资助金额:
$ 18.69万 - 项目类别:
In Situ Hybridization and Immunohistochemistry Core
原位杂交和免疫组织化学核心
- 批准号:
8326904 - 财政年份:2011
- 资助金额:
$ 18.69万 - 项目类别:
TOPICAL MICROBICIDE AGAINST SIV AND CHLAMYDIA
针对 SIV 和衣原体的局部杀菌剂
- 批准号:
8358219 - 财政年份:2011
- 资助金额:
$ 18.69万 - 项目类别:
Impact of Extraordinarily Large Numbers of SIV-specific CD8 T Cells on Vaginal Tr
大量 SIV 特异性 CD8 T 细胞对阴道 Tr 的影响
- 批准号:
8293429 - 财政年份:2010
- 资助金额:
$ 18.69万 - 项目类别:
Microarray Studies to Discover Novel Host Defenses in SIV Infection
微阵列研究发现 SIV 感染的新型宿主防御
- 批准号:
8010734 - 财政年份:2010
- 资助金额:
$ 18.69万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 18.69万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 18.69万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 18.69万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 18.69万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 18.69万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 18.69万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 18.69万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 18.69万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 18.69万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 18.69万 - 项目类别:
Standard Grant